Discovery and preclinical validation of a translationally optimized mitochondrial complex I modulator for Alzheimer’s disease
Findings establish mild modulation of mtCI as a therapeutic strategy to restore metabolic resilience and identify C273 as a promising disease-modifying candidate for AD treatment.